VIGIL - Use of PCR-SARS-CoV-2 in Children (VIGIL)
Head :
JUNG Camille
Last update : 05/05/2021 | Version : 1 | ID : 73890
| General | |
| Identification | |
| Detailed name | Use of PCR-SARS-CoV-2 in Children (VIGIL) |
| Sign or acronym | VIGIL |
| CNIL registration number, number and date of CPP agreement, AFSSAPS (French Health Products Safety Agency) authorisation | NCT04412317 |
| General Aspects | |
| Medical area |
Infectious diseases |
| Study in connection with Covid-19 |
Yes |
| Scientific investigator(s) (Contact) | |
| Name of the director | JUNG |
| Surname | Camille |
| camille.jung@chicreteil.fr | |
| Collaborations | |
| Participation in projects, networks and consortia |
Yes |
| Funding | |
| Governance of the database | |
| Sponsor(s) or organisation(s) responsible | Créteil Intermunicipal Hospital |
| Organisation status |
Public |
| Presence of scientific or steering committees |
Yes |
| Additional contact | |
| Name of the contact | LEVY |
| Surname | Corinne |
| corinne.levy@activ-france.fr | |
| Organization | ACTIV |
| Main features | |
| Type of database | |
| Type of database |
Study databases |
| Study databases (details) |
Cohort study |
| Database recruitment is carried out by an intermediary |
A selection of health care professionals |
| Database recruitment is carried out as part of an interventional study |
No |
| Database objective | |
| Main objective | Percentage of patients positive for Covid-19 |
| Inclusion criteria |
Children <15 years
indication for PCR or rapid antigen test for Covid-19 |
| Population type | |
| Age |
Newborns (birth to 28 days) Infant (28 days to 2 years) Early childhood (2 to 5 years) Childhood (6 to 13 years) Adolescence (13 to 18 years) |
| Population covered |
General population |
| Pathology | |
| Gender |
Male Woman |
| Geography area |
National |
| Data collection | |
| Dates | |
| Size of the database | |
| Size of the database (number of individuals) |
[500-1000[ individuals |
| Data | |
| Database activity |
Current data collection |
| Type of data collected |
Clinical data Paraclinical data |
| Presence of a biobank |
No |
| Procedures | |
| Followed pathology | |
| Promotion and access | |
| Promotion | |
| Access |
